Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.1K Sell
641
-393
-38% -$37K ﹤0.01% 289
2026
Q1
$122K Sell
1,034
-185
-15% -$22.9K 0.01% 192
2025
Q4
$153K Sell
1,219
-307
-20% -$40K 0.01% 166
2025
Q3
$223K Sell
1,526
-501
-25% -$75.7K 0.01% 150
2025
Q2
$316K Sell
2,027
-39
-2% -$6.18K 0.02% 114
2025
Q1
$340K Sell
2,066
-561
-21% -$93.3K 0.03% 111
2024
Q4
$428K Buy
2,627
+1,800
+218% +$322K 0.03% 98
2024
Q3
$162K Hold
827
0.01% 135
2024
Q2
$143K Sell
827
-573
-41% -$95.4K 0.01% 146
2024
Q1
$237K Sell
1,400
-137
-9% -$25.7K 0.02% 123
2023
Q4
$303K Hold
1,537
0.03% 105
2023
Q3
$267K Sell
1,537
-29
-2% -$5.26K 0.03% 100
2023
Q2
$270K Hold
1,566
0.02% 111
2023
Q1
$261K Buy
+1,566
New +$257K 0.03% 108

Other funds holding ZTS

Avalon Trust's ZTS Position: Q2 2026 in Review

Avalon Trust reduced its Zoetis (ZTS) stake by 38% in Q2 2026, selling an estimated $37K and leaving 641 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Avalon Trust first reported a position in ZTS in Q1 2023 and has held it in 14 quarters since. The position peaked at $428K in Q4 2024. 1,423 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Avalon Trust held 641 shares of Zoetis worth $46.1K as of Q2 2026.
  • Avalon Trust sold 393 Zoetis shares in Q2 2026, an estimated $37K.
  • Zoetis made up ﹤0.01% of Avalon Trust's portfolio in Q2 2026, its #289 holding.
  • Avalon Trust first reported a position in Zoetis in Q1 2023 and has held it in 14 quarters since.
  • Avalon Trust's Zoetis position peaked at $428K in Q4 2024.
  • 1,423 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.